There are no large studies available regarding the possible fertility preservation effect of GnRH agonist co-treatment in the cases of premenopausal women treated with chemotherapy due to ovarian, endometrial, or cervical cancer, and thus we have inconclusive data. The gene discussed is GNRH1; the disease is cervical carcinoma.